Jasper Therapeutics所有资讯

ARS：年度报告

04/22 13:56 (美东)

DEFA14A：其他

04/22 13:41 (美东)

DEF 14A：股东委托书决议

04/22 13:16 (美东)

Jasper Therapeutics | SC 13G：超过5%持股股东披露文件-Avidity Partners Management LP(5.1%),Avidity Partners Management (GP) LLC(5.1%)等

03/27 16:32 (美东)

Jasper Therapeutics | 4：持股变动声明-高管 Mahal Jeetinder Singh

03/12 21:34 (美东)

Jasper Therapeutics | 144：拟议出售证券

03/12 20:54 (美东)

Jasper Therapeutics | 144：拟议出售证券

03/06 17:50 (美东)

Jasper Therapeutics | S-8：员工福利计划证券登记

03/05 16:58 (美东)

Jasper Therapeutics | 10-K：年度报表

03/05 16:04 (美东)

Jasper Therapeutics | 8-K：重大事件

03/04 07:45 (美东)

Jasper Therapeutics | 4：持股变动声明-高管 MARTELL RON

02/20 19:34 (美东)

Jasper Therapeutics | 4：持股变动声明-高管 Mahal Jeetinder Singh

02/20 19:34 (美东)

Jasper Therapeutics | 4：持股变动声明-高管 CROSS HERB

02/20 19:29 (美东)

Jasper Therapeutics | 4：持股变动声明-高管 Tucker Edwin Jonathan

02/20 19:24 (美东)

Jasper Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Citadel Securities LLC(0.2%),Citadel Securities Group LP(0.2%)等

02/14 18:24 (美东)

Jasper Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Qiming U.S. Healthcare Fund II, L.P.(6.2%),Qiming U.S. Healthcare GP II, LLC(6.2%)等

02/14 17:41 (美东)

Jasper Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等

02/14 09:42 (美东)

Jasper Therapeutics | 4：持股变动声明- Carlyle Group Inc.

02/12 18:25 (美东)

Jasper Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-The Carlyle Group Inc.(7.1%),Carlyle Holdings I GP Inc.(7.1%)等

02/12 18:05 (美东)

Jasper Therapeutics | 4：持股变动声明-股东 Velan Capital Investment Management LP

02/09 20:45 (美东)